Loading...
The development of anticancer ruthenium(II) complexes: from single molecule compounds to nanomaterials
Cancer is rapidly becoming the top killer in the world. Most of the FDA approved anticancer drugs are organic molecules, while metallodrugs are very scarce. The advent of first metal based therapeutic agent, cisplatin, launched a new era in the application of transition metal complexes for therapeut...
Na minha lista:
| Udgivet i: | Chem Soc Rev |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5624840/ https://ncbi.nlm.nih.gov/pubmed/28654103 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1039/c7cs00195a |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|